Pramote Tragulpiankit

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Body Mass Index

Randomized Controlled Trial

Pulmonary Tuberculosis

Top Venues

Clinical and translational science

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, Pramote Tragulpiankit
Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. Clinical and translational science 17 (4) (2024)
Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, Pramote Tragulpiankit
Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. Clinical and translational science 17 (4) (2024)
Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, Pramote Tragulpiankit
Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. Clinical and translational science 17 (4) (2024)
Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, Pramote Tragulpiankit
Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. Clinical and translational science 17 (4) (2024)
Francis R Capule, Pramote Tragulpiankit, Surakameth Mahasirimongkol, Jiraphun Jittikoon, Nuanjun Wichukchinda, Lara Theresa Alentajan-Aleta, Jay-V James G Barit, Josephine Casanova-Gutierrez, Leonor Cabral-Lim, Jose Paciano Baltazar Reyes, Francisca Roa, Raymark Salonga, Katrina Faith San Gabriel, Catherine Lynn Silao
HLA-A*24:07 as a potential biomarker for carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Filipino patients. Pharmacogenomics 22 (8) (2021)